Systemic Sclerosis

Possible adaptations of vascularised human skin equivalents to include rare cell populations and study fibroblast heterogeneity. Response to: ‘In search for the ideal anatomical composition of vascularised human skin equivalents for systemic sclerosis translational research: should we recruit the telocytes?’ by Manetti and Matucci-Cerinic
Alexandru Emil Matei, Jörg H W Distler

Annals of the Rheumatic Diseases Oct 2019, annrheumdis-2019-216393; DOI: 10.1136/annrheumdis-2019-216393
Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis
Minghua Wu, Brian Skaug, Xiongjie Bi, Tingting Mills, Gloria Salazar, Xiaodong Zhou, John Reveille, Sandeep K Agarwal, Michael R Blackburn, Maureen D Mayes, Shervin Assassi

Annals of the Rheumatic Diseases Nov 2019, 78 (11) 1583-1591; DOI: 10.1136/annrheumdis-2019-215208
Effectiveness and safety of tocilizumab for the treatment of refractory systemic sclerosis associated interstitial lung disease: a case series
Javier Narváez, Judit LLuch, Juan José Alegre Sancho, Maria Molina-Molina, Joan Miquel Nolla, Ivan Castellví

Annals of the Rheumatic Diseases Nov 2019, 78 (11) e123; DOI: 10.1136/annrheumdis-2018-214449
Response to: ‘Effectiveness and safety of tocilizumab for the treatment of refractory systemic sclerosis associated interstitial lung disease: a case series’ by Narváez
Dinesh Khanna, Angelika Jahreis, Celia J F Lin

Annals of the Rheumatic Diseases Nov 2019, 78 (11) e124; DOI: 10.1136/annrheumdis-2018-214477
Response to: ‘Will SPAR be useful in the usual patients with scleroderma?’ by Chattopadhyay et al
Wanlong Wu, Suzana Jordan, Oliver Distler

Annals of the Rheumatic Diseases Nov 2019, 78 (11) e126; DOI: 10.1136/annrheumdis-2018-214270
M1/M2 polarisation state of M-CSF blood-derived macrophages in systemic sclerosis
Alain Lescoat, Alice Ballerie, Stephane Jouneau, Olivier Fardel, Laurent Vernhet, Patrick Jego, Valérie Lecureur

Annals of the Rheumatic Diseases Nov 2019, 78 (11) e127; DOI: 10.1136/annrheumdis-2018-214333
Monocyte and macrophage phenotypes: a look beyond systemic sclerosis. Response to: 'M1/M2 polarisation state of M-CSF blood-derived macrophages in systemic sclerosis' by Lescoat et al
Maurizio Cutolo, Amelia Chiara Trombetta, Stefano Soldano

Annals of the Rheumatic Diseases Nov 2019, 78 (11) e128; DOI: 10.1136/annrheumdis-2018-214371
Shared genetic factors and their causality in autoimmune diseases
Kazuhiko Yamamoto, Yukinori Okada

Annals of the Rheumatic Diseases Nov 2019, 78 (11) 1449-1451; DOI: 10.1136/annrheumdis-2019-215099
Getting to the heart of the matter: detecting and managing cardiac complications in systemic sclerosis
John Varga, Daniel C Lee

Annals of the Rheumatic Diseases Nov 2019, 78 (11) 1452-1453; DOI: 10.1136/annrheumdis-2019-216115
Overlap of systemic lupus erythematosus and myositis is rare in anti-Ku antibody-positive patients
Mariko Ogawa-Momohara, Yoshinao Muro, Masashi Akiyama

Annals of the Rheumatic Diseases Oct 2019, annrheumdis-2019-216375; DOI: 10.1136/annrheumdis-2019-216375

Main menu

Systemic Sclerosis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Systemic Sclerosis

Pages